SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.

D N Middlemiss; M Göthert; E Schlicker; C M Scott; J V Selkirk; J Watson; L M Gaster; P Wyman; G Riley; G W Price

doi:10.1016/s0014-2999(99)00262-9

SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.

Identifier:nobleid.org/w1/20260515/0830EBC9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0830EBC9.svg?ark=w1%2F20260515%2F0830EBC9)](https://nobleid.org/work/w1/20260515/0830EBC9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.

Identifier:nobleid.org/w1/20260515/0830EBC9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0830EBC9.svg?ark=w1%2F20260515%2F0830EBC9)](https://nobleid.org/work/w1/20260515/0830EBC9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work